Literature DB >> 17043646

No evidence for dual role of loss of heterozygosity in hereditary non-polyposis colorectal cancer.

S Tuupanen1, A Karhu, H Järvinen, J P Mecklin, V Launonen, L A Aaltonen.   

Abstract

Hereditary non-polyposis colorectal cancer (HNPCC) is caused by germline mutations in mismatch repair (MMR) genes, mostly MLH1 and MSH2. Somatic inactivation of the wild-type allele of the respective MMR gene is required for tumor development. Unexpectedly, a recent study utilizing DNA from paraffin-embedded tissue material detected frequent loss of the mutant MMR gene allele in HNPCC tumors. Dual role for loss of heterozygosity (LOH) was proposed. If somatic loss of the wild-type MMR gene allele had occurred through point mutation or promoter hypermethylation, frequent somatic deletions at the region of the MMR gene locus, perhaps targeting other relevant cancer genes, could quite commonly lead to loss of the mutant allele. To test this hypothesis, we studied a population-based series of 25 fresh-frozen HNPCC tumors with a germline mutation in MLH1 or MSH2 for LOH. Fourteen of the 25 tumors (56%) showed LOH at the respective locus, and all 14 losses targeted the wild-type allele (P=0.00006). These results strongly support the traditional two-hit model of HNPCC gene inactivation.

Entities:  

Mesh:

Year:  2006        PMID: 17043646     DOI: 10.1038/sj.onc.1210038

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  MYH biallelic mutation can inactivate the two genetic pathways of colorectal cancer by APC or MLH1 transversions.

Authors:  Jérémie H Lefevre; Chrystelle Colas; Florence Coulet; Carolina Bonilla; Najat Mourra; Jean-Francois Flejou; Emmanuel Tiret; Walter Bodmer; Florent Soubrier; Yann Parc
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

2.  Gene variants of unknown clinical significance in Lynch syndrome. An introduction for clinicians.

Authors:  Rolf H Sijmons; Marc S Greenblatt; Maurizio Genuardi
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

3.  Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance.

Authors:  Robert M W Hofstra; Amanda B Spurdle; Diana Eccles; William D Foulkes; Niels de Wind; Nicoline Hoogerbrugge; Frans B L Hogervorst
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

Review 4.  Promoter methylation in the genesis of gastrointestinal cancer.

Authors:  Clement Richard Boland; Sung Kwan Shin; Ajay Goel
Journal:  Yonsei Med J       Date:  2009-06-23       Impact factor: 2.759

5.  Genome-wide copy neutral LOH is infrequent in familial and sporadic microsatellite unstable carcinomas.

Authors:  Marjo van Puijenbroek; Anneke Middeldorp; Carli M J Tops; Ronald van Eijk; Heleen M van der Klift; Hans F A Vasen; Juul Th Wijnen; Frederik J Hes; Jan Oosting; Tom van Wezel; Hans Morreau
Journal:  Fam Cancer       Date:  2008-04-15       Impact factor: 2.375

6.  Unbalanced replication as a major source of genetic instability in cancer cells.

Authors:  Daniel Corcos
Journal:  Am J Blood Res       Date:  2012-10-20

7.  Ultradeep sequencing of a human ultraconserved region reveals somatic and constitutional genomic instability.

Authors:  Anna De Grassi; Cinzia Segala; Fabio Iannelli; Sara Volorio; Lucio Bertario; Paolo Radice; Loris Bernard; Francesca D Ciccarelli
Journal:  PLoS Biol       Date:  2010-01-05       Impact factor: 8.029

8.  Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers.

Authors:  Katarina Zavodna; Tomas Krivulcik; Maria Gerykova Bujalkova; Tomas Slamka; David Martinicky; Denisa Ilencikova; Zdena Bartosova
Journal:  BMC Cancer       Date:  2009-11-20       Impact factor: 4.430

9.  Functional analysis in mouse embryonic stem cells reveals wild-type activity for three MSH6 variants found in suspected Lynch syndrome patients.

Authors:  Eva A L Wielders; Hellen Houlleberghs; Gözde Isik; Hein te Riele
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

10.  Epigenetic Loss of MLH1 Expression in Normal Human Hematopoietic Stem Cell Clones is Defined by the Promoter CpG Methylation Pattern Observed by High-Throughput Methylation Specific Sequencing.

Authors:  Jonathan Kenyon; Gabrielle Nickel-Meester; Yulan Qing; Gabriela Santos-Guasch; Ellen Drake; Shuying Sun; Xiaodong Bai; David Wald; Eric Arts; Stanton L Gerson
Journal:  Int J Stem Cell Res Ther       Date:  2016-05-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.